A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia

Clinical trial NCT00249158 · COMPLETED

Trial details

NCT number: NCT00249158
Sponsor: Janssen-Cilag Pty Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Dementia Alzheimer Disease Vascular Dementia

Start date: 1998-03-01
Enrollment: 344

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.